Article
Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives.
International journal of molecular sciences - 29 Sept 2024
Bojtor Bence, Balla Bernadett, Vaszilko Mihaly, Szentpeteri Szofia, Putz Zsuzsanna, Kosa Janos P, Lakatos Peter
Abstract excerpt
Medication-related osteonecrosis of the jaw (MRONJ) is a rare side effect of antiresorptive drugs that significantly hinders the quality of life of affected patients. The disease develops in the presence of a combination of factors. Important pathogenetic factors include inflammation, inhibition of bone remodeling, or genetic predisposition. Since the first description of this rare side effect in 2003, a growing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
